Literature DB >> 34006888

Programmably tiling rigidified DNA brick on gold nanoparticle as multi-functional shell for cancer-targeted delivery of siRNAs.

Chang Xue1, Shuyao Hu1, Zhi-Hua Gao2, Lei Wang3, Meng-Xue Luo1, Xin Yu1, Bi-Fei Li1, Zhifa Shen2, Zai-Sheng Wu4.   

Abstract

Small interfering RNA (siRNA) is an effective therapeutic to regulate the expression of target genes in vitro and in vivo. Constructing a siRNA delivery system with high serum stability, especially responsive to endogenous stimuli, remains technically challenging. Herein we develop anti-degradation Y-shaped backbone-rigidified triangular DNA bricks with sticky ends (sticky-YTDBs) and tile them onto a siRNA-packaged gold nanoparticle in a programmed fashion, forming a multi-functional three-dimensional (3D) DNA shell. After aptamers are arranged on the exterior surface, a biocompatible siRNA-encapsulated core/shell nanoparticle, siRNA/Ap-CS, is achieved. SiRNAs are internally encapsulated in a 3D DNA shell and are thus protected from enzymatic degradation by the outermost layer of YTDB. The siRNAs can be released by endogenous miRNA and execute gene silencing within tumor cells, causing cell apoptosis higher than Lipo3000/siRNA formulation. In vivo treatment shows that tumor growth is completely (100%) inhibited, demonstrating unique opportunities for next-generation anticancer-drug carriers for targeted cancer therapies.

Entities:  

Year:  2021        PMID: 34006888     DOI: 10.1038/s41467-021-23250-5

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  46 in total

Review 1.  Clinical advances of siRNA therapeutics.

Authors:  Bo Hu; Yuhua Weng; Xin-Hua Xia; Xing-Jie Liang; Yuanyu Huang
Journal:  J Gene Med       Date:  2019-06-17       Impact factor: 4.565

2.  Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference.

Authors:  Jiahe Li; Connie Wu; Wade Wang; Yanpu He; Elad Elkayam; Leemor Joshua-Tor; Paula T Hammond
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

3.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

Review 4.  RNA interference in the clinic: challenges and future directions.

Authors:  Chad V Pecot; George A Calin; Robert L Coleman; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2010-12-16       Impact factor: 60.716

5.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.

Authors:  Lydia Alvarez-Erviti; Yiqi Seow; Haifang Yin; Corinne Betts; Samira Lakhal; Matthew J A Wood
Journal:  Nat Biotechnol       Date:  2011-03-20       Impact factor: 54.908

6.  siRNA-mediated gene silencing in vitro and in vivo.

Authors:  Haibin Xia; Qinwen Mao; Henry L Paulson; Beverly L Davidson
Journal:  Nat Biotechnol       Date:  2002-09-16       Impact factor: 54.908

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

8.  Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment.

Authors:  João Conde; Nuria Oliva; Mariana Atilano; Hyun Seok Song; Natalie Artzi
Journal:  Nat Mater       Date:  2015-12-07       Impact factor: 43.841

9.  Self-assembly of DNA nanohydrogels with controllable size and stimuli-responsive property for targeted gene regulation therapy.

Authors:  Juan Li; Cheng Zheng; Sena Cansiz; Cuichen Wu; Jiehua Xu; Cheng Cui; Yuan Liu; Weijia Hou; Yanyue Wang; Liqin Zhang; I-ting Teng; Huang-Hao Yang; Weihong Tan
Journal:  J Am Chem Soc       Date:  2015-01-26       Impact factor: 15.419

10.  Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription.

Authors:  Mihue Jang; Jong Hwan Kim; Hae Yun Nam; Ick Chan Kwon; Hyung Jun Ahn
Journal:  Nat Commun       Date:  2015-08-06       Impact factor: 14.919

View more
  5 in total

Review 1.  Exosome-based drug delivery systems and their therapeutic applications.

Authors:  Jaewook Lee; Ji-Heon Lee; Kushal Chakraborty; Joon Hwang; Yong-Kyu Lee
Journal:  RSC Adv       Date:  2022-06-23       Impact factor: 4.036

Review 2.  Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives.

Authors:  Madhusudhan Alle; Garima Sharma; Seung-Hwan Lee; Jin-Chul Kim
Journal:  J Nanobiotechnology       Date:  2022-07-02       Impact factor: 9.429

Review 3.  Nanocarriers for delivery of siRNA as gene silencing mediator.

Authors:  Aideé Morales-Becerril; Liliana Aranda-Lara; Keila Isaac-Olivé; Blanca E Ocampo-García; Enrique Morales-Ávila
Journal:  EXCLI J       Date:  2022-08-01       Impact factor: 4.022

4.  Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.

Authors:  Weinan Guo; Zhenjie Wu; Jianru Chen; Sen Guo; Weiming You; Sijia Wang; Jinyuan Ma; Huina Wang; Xiangxu Wang; Hao Wang; Jingjing Ma; Yuqi Yang; Yangzi Tian; Qiong Shi; Tianwen Gao; Xiuli Yi; Chunying Li
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 5.  Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics.

Authors:  Mina Zare; Rakesh Pemmada; Maya Madhavan; Aswathy Shailaja; Seeram Ramakrishna; Sumodan Padikkala Kandiyil; James M Donahue; Vinoy Thomas
Journal:  Pharmaceutics       Date:  2022-08-03       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.